NDRA (ENDRA Life Sciences) Total Liabilities: $1.65 Mil (As of Mar. 2026)


NDRA ENDRA Life Sciences Inc NDRA
25 GF Score
Price $4.72
! 2 Warning Signs
View Full Analysis

What is ENDRA Life Sciences Total Liabilities?

ENDRA Life Sciences NDRA -4.84% 25 Total Liabilities is $1.65 Mil as of Mar. 2026. GuruFocus rates NDRA with a GF Score™ of 25/100. The stock has 2 warning signs investors should review.

ENDRA Life Sciences's Total Liabilities for the quarter that ended in Mar. 2026 was $1.65 Mil.

ENDRA Life Sciences's quarterly Total Liabilities declined from Sep. 2025 ($1.79 Mil) to Dec. 2025 ($1.59 Mil) but then increased from Dec. 2025 ($1.59 Mil) to Mar. 2026 ($1.65 Mil).

ENDRA Life Sciences's annual Total Liabilities increased from Dec. 2023 ($1.10 Mil) to Dec. 2024 ($1.89 Mil) but then declined from Dec. 2024 ($1.89 Mil) to Dec. 2025 ($1.59 Mil).


ENDRA Life Sciences Total Liabilities Historical Data

* Premium members only.

The historical data trend for ENDRA Life Sciences's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ENDRA Life Sciences Total Liabilities Chart

ENDRA Life Sciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.09 2.07 1.10 1.89 1.59

ENDRA Life Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.42 1.34 1.79 1.59 1.65
NDRA
25GF Score
ENDRA Life Sciences Inc NDRA
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ENDRA Life Sciences Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

ENDRA Life Sciences's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=3.854-2.26
=1.59

ENDRA Life Sciences's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.835+(0.327+0.489
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=1.65

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=3.438-1.787
=1.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $1.65 Mil mean?
ENDRA Life Sciences (NDRA) has a Total Liabilities of $1.65 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for ENDRA Life Sciences and its competitors.
Is ENDRA Life Sciences' Total Liabilities too high?
ENDRA Life Sciences' current Total Liabilities is $1.65 Mil. Overall, ENDRA Life Sciences has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does ENDRA Life Sciences' Total Liabilities compare to BIAF and ADVB?
ENDRA Life Sciences' Total Liabilities of $1.65 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Diagnostics & Research company?
A good Total Liabilities depends on the Medical Diagnostics & Research industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for ENDRA Life Sciences and its competitors. ENDRA Life Sciences's current Total Liabilities is $1.65 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ENDRA Life Sciences stock overvalued right now?
ENDRA Life Sciences (NDRA) has a current Total Liabilities of $1.65 Mil. The current Total Liabilities is $1.65 Mil. ENDRA Life Sciences' overall GF Score™ is 25/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For ENDRA Life Sciences (NDRA), the current Total Liabilities is $1.65 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ENDRA Life Sciences Business Description

Address 3600 Green Court, Suite 350, Ann Arbor, MI, USA, 48105-1570
ENDRA Life Sciences Inc is engaged in the development of thermo-acoustic enhanced ultrasound (TAEUS) technology to improve the capabilities of clinical diagnostic ultrasound. The company's technology is used to measure tissue composition, including the assessment of fat in the liver, and is being developed for additional clinical applications such as tissue temperature monitoring.
25GF Score

Get the complete analysis for NDRA

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.72
Price